Collegium Pharmaceutical
COLL
COLL
120 hedge funds and large institutions have $580M invested in Collegium Pharmaceutical in 2018 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 40 increasing their positions, 48 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
3% less funds holding
Funds holding: 124 → 120 (-4)
16% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 19
17% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 48
Holders
120
Holding in Top 10
3
Calls
$1.2M
Puts
$319K
Top Buyers
| 1 | +$20.1M | |
| 2 | +$7.37M | |
| 3 | +$6.29M | |
| 4 |
UBS AM
Chicago,
Illinois
|
+$5.03M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$3.81M |
Top Sellers
| 1 | -$14.3M | |
| 2 | -$8.84M | |
| 3 | -$8.19M | |
| 4 |
MC
Maverick Capital
Dallas,
Texas
|
-$6.22M |
| 5 |
Two Sigma Investments
New York
|
-$3.37M |